Author:
Tyukavin Alexander I.,Arseniev Nikolay А.,Studneva Maria A.,Medvedeva Veronika S.,Suchkov Sergey V.
Abstract
The review discusses the role of pharmaceutical and drug design methodology in the development of the high-tech segment of the development and production of original drugs for personalized and precision medicine (PPM). Topical issues of using predictively personalized tools for precision medicine in pharmaceuticals are highlighted. New opportunities and prospects for increasing the effectiveness of drugs in various fields of medicine created on the basis of pharmaceutical design are shown. Discussed are original approaches to standardization and reproducibility of the effects of new drugs at the preclinical stage using microfluidic bioconstructs organ-on-a-chip systems. The relevance of improving university curricula for training specialists in the field of molecular drug design (drug design), harmonized with dynamically developing biotechnologies in pharmaceuticals, as well as the needs of domestic healthcare in original medicines for PPM, is shown.
Subject
Materials Science (miscellaneous)
Reference10 articles.
1. Suchkova S.V., ed. Osnovy personalizirovannoj i precizionnoj mediciny. Uchebnik dlja medicinskih vuzov i fakul'tetov Kazan: ID MedDok; 2021. 628 p. (In Russ.).
2. Tyukavin A.I., ed. Patologija: uchebnik. Moscow: INFRA-M; 2021. 844 p. (In Russ.).
3. Chaplenko A.A., Vlasov V.V., Gildeeva G.N. Innovative medicines on the Russian pharmaceutical market: key players and main directions of development. Remedium. 2020;(10):4–9. https://doi.org/10.21518/1561-5936-2020-10-4-9. (In Russ.).
4. The Pharma Media: BioMedTracker and Cortellis databases.
5. Okminyan G.F., Latyshev O.Yu., Kiseleva E.V., et al. Basal insulin evolution: from simple to more complex. Endokrinologiya: novosti, mneniya, obuchenie = Endocrinology: News, Opinions, Training. 2021;10(1):18–25. https://doi.org/10.33029/2304-9529-2021-10-1-18-25. (In Russ.).